Human GUCY2C-targeted chimeric antigen receptor (CAR)-expressing T cells eliminate colorectal cancer metastases

Overview of attention for article published in Cancer Immunology Research, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 1,945)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 54 news outlets
blogs: 1 blog
twitter: 14 X users

patent: 18 patents
googleplus: 1 Google+ user
reddit: 1 Redditor

Readers on

mendeley: 157 Mendeley

So far, Altmetric has seen 54 news stories from 54 outlets.

Colorectal cancer: Treatment looks set for human clinical trials

Medical News Today, 03 May 2018

A treatment type that uses patients' own immune cells to attack cancer looks ready for testing in human clinical trials of…

CAR-T immunotherapy eliminates metastatic colorectal cancer in mice. ecancer

ecancer, 02 May 2018

Immunotherapy has given patients and oncologists new options, which for some patients, has meant cures for diseases that had…

CAR-T Immunotherapy Eliminates Metastatic Colorectal Cancer in Mice

Houston Chronicle, 01 May 2018

PRWeb Published 6:00 pm, Tuesday, May 1, 2018 A CAR-T-based immunotherapy successfully kills tumors and prevents metastatic…

CAR-T Immunotherapy Eliminates Metastatic Colorectal Cancer in Mice

My San Antonio, 01 May 2018

A CAR-T-based immunotherapy successfully kills tumors and prevents metastatic growth, in final preclinical tests before human…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 50 additional news stories.